XML 53 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 16 - Condensed Consolidating Financial Information of Guarantor Subsidiaries (Tables)
9 Months Ended
Feb. 28, 2014
Disclosure Text Block Supplement [Abstract]  
Condensed Balance Sheet [Table Text Block]
   

Immucor, Inc.

   

Guarantors

   

Non-Guarantors

   

Eliminations

   

Total

 
                                         

ASSETS

                                       
                                         

CURRENT ASSETS:

                                       

Cash and cash equivalents

  $ 4,654       (232 )     21,606       -       26,028  

Accounts receivable, net

    29,899       4,605       32,182       -       66,686  

Intercompany receivable

    55,103       11,406       7,914       (74,423 )     -  

Inventories

    21,667       16,657       14,585       (1,801 )     51,108  

Deferred income tax assets, current portion

    3,599       2,209       377       695       6,880  

Prepaid expenses and other current assets

    5,494       710       5,447       -       11,651  

Total current assets

    120,416       35,355       82,111       (75,529 )     162,353  
                                         

PROPERTY AND EQUIPMENT, net

    38,069       16,577       21,316       -       75,962  

INVESTMENT IN SUBSIDIARIES

    248,548       5,021       3,705       (257,274 )     -  

GOODWILL

    903,513       42,053       60,212       -       1,005,778  

OTHER INTANGIBLE ASSETS, net

    598,227       37,480       43,966       -       679,673  

DEFERRED FINANCING COSTS

    34,736       -       -       -       34,736  

OTHER ASSETS

    6,394       187       339       -       6,920  

Total assets

  $ 1,949,903       136,673       211,649       (332,803 )     1,965,422  
                                         

LIABILITIES AND SHAREHOLDERS' EQUITY

                                       
                                         

CURRENT LIABILITIES:

                                       

Accounts payable

  $ 8,982       5,154       3,073       -       17,209  

Intercompany payable

    320       64,030       10,073       (74,423 )     -  

Accrued interest and interest rate swap liability

    8,359       -       -       -       8,359  

Accrued expenses and other current liabilities

    7,959       4,653       9,961       -       22,573  

Income taxes payable

    31,162       (30,612 )     5,330       -       5,880  

Deferred revenue, current portion

    1,215       15       1,411       -       2,641  

Current portion of long-term debt, net of debt discounts

    4,606       18       -       -       4,624  

Total current liabilities

    62,603       43,258       29,848       (74,423 )     61,286  
                                         

LONG-TERM DEBT, NET OF DEBT DISCOUNTS

    1,038,170       15       -       -       1,038,185  

DEFERRED REVENUE

    22       -       98       -       120  

DEFERRED INCOME TAX LIABILITIES

    202,925       3,064       12,168       -       218,157  

OTHER LONG-TERM LIABILITIES

    10,927       128       1,363       -       12,418  

Total liabilities

    1,314,647       46,465       43,477       (74,423 )     1,330,166  

SHAREHOLDERS' EQUITY:

                                       

Total shareholders' equity

    635,256       90,208       168,172       (258,380 )     635,256  

Total liabilities and shareholders' equity

  $ 1,949,903       136,673       211,649       (332,803 )     1,965,422  
   

Immucor, Inc.

   

Guarantors

   

Non-Guarantors

   

Eliminations

   

Total

 
                                         

ASSETS

                                       
                                         

CURRENT ASSETS:

                                       

Cash and cash equivalents

  $ 6,971       4,107       18,310       -       29,388  

Accounts receivable, net

    26,517       5,552       36,017       -       68,086  

Intercompany receivable

    54,443       7,961       4,313       (66,717 )     -  

Inventories

    18,551       15,897       12,978       (1,485 )     45,941  

Deferred income tax assets, current portion

    3,098       1,097       533       562       5,290  

Prepaid expenses and other current assets

    6,360       483       4,734       -       11,577  

Total current assets

    115,940       35,097       76,885       (67,640 )     160,282  
                                         

PROPERTY AND EQUIPMENT, net

    40,124       17,060       19,197       -       76,381  

INVESTMENT IN SUBSIDIARIES

    248,150       5,743       4       (253,897 )     -  

GOODWILL

    903,802       41,763       57,898       -       1,003,463  

OTHER INTANGIBLE ASSETS, net

    634,194       39,523       40,886       -       714,603  

DEFERRED FINANCING COSTS

    39,449       -       -       -       39,449  

OTHER ASSETS

    6,203       184       405       -       6,792  

Total assets

  $ 1,987,862       139,370       195,275       (321,537 )     2,000,970  
                                         

LIABILITIES AND SHAREHOLDERS' EQUITY

                                       
                                         

CURRENT LIABILITIES:

                                       

Accounts payable

  $ 7,587       3,315       2,736       -       13,638  

Intercompany payable

    424       59,347       7,440       (67,211 )     -  

Accrued expenses and other current liabilities

    31,737       5,290       9,711       -       46,738  

Income taxes payable

    30,879       (30,457 )     3,451       -       3,873  

Deferred revenue, current portion

    1,086       6       1,160       -       2,252  

Current portion of long-term debt, net of debt discounts

    6,673       39       -       -       6,712  

Total current liabilities

    78,386       37,540       24,498       (67,211 )     73,213  
                                         

LONG-TERM DEBT, net of debt discounts

    1,039,250       28       -       -       1,039,278  

DEFERRED REVENUE

    62       -       99       -       161  

DEFERRED INCOME TAX LIABILITIES

    214,222       4,861       11,957       -       231,040  

OTHER LONG-TERM LIABILITIES

    11,236       114       1,222       -       12,572  

Total liabilities

    1,343,156       42,543       37,776       (67,211 )     1,356,264  

SHAREHOLDERS' EQUITY:

                                       

Total shareholders' equity

    644,706       96,827       157,499       (254,326 )     644,706  

Total liabilities and shareholders' equity

  $ 1,987,862       139,370       195,275       (321,537 )     2,000,970  
Condensed Income Statement [Table Text Block]
   

Immucor, Inc.

   

Guarantors

   

Non-Guarantors

   

Eliminations

   

Total

 
                                         

NET SALES

  $ 57,604       12,252       35,988       (14,865 )     90,979  

COST OF SALES (exclusive of amortization shown separately below)

    19,737       6,402       21,085       (14,865 )     32,359  

GROSS MARGIN

    37,867       5,850       14,903       -       58,620  
                                         

OPERATING EXPENSES:

                                       

Research and development

    3,212       3,397       129       -       6,738  

Selling and marketing

    5,673       2,311       6,311       -       14,295  

Distribution

    2,921       345       1,802       -       5,068  

General and administrative

    6,943       1,647       1,720       -       10,310  

Amortization of intangibles

    11,971       658       596       -       13,225  

Impairment loss

    -       150       -       -       150  

Total operating expenses

    30,720       8,508       10,558       -       49,786  
                                         

INCOME (LOSS) FROM OPERATIONS

    7,147       (2,658 )     4,345       -       8,834  
                                         

NON-OPERATING INCOME (EXPENSE):

                                       

Interest income

    -       6       21       (11 )     16  

Interest expense

    (21,900 )     -       (11 )     11       (21,900 )

Other, net

    (186 )     24       54       -       (108 )

Total non-operating (expense) income

    (22,086 )     30       64       -       (21,992 )
                                         

(LOSS) INCOME BEFORE INCOME TAXES

    (14,939 )     (2,628 )     4,409       -       (13,158 )

(BENEFIT) PROVISION FOR INCOME TAXES

    (6,255 )     (952 )     1,404       -       (5,803 )

NET (LOSS) INCOME BEFORE EARNINGS OF CONSOLIDATED SUBSIDIARIES

    (8,684 )     (1,676 )     3,005       -       (7,355 )

Net (Loss) Income of consolidated subsidiaries

    1,329       -       -       (1,329 )     -  

NET (LOSS) INCOME

  $ (7,355 )     (1,676 )     3,005       (1,329 )     (7,355 )
   

Immucor, Inc.

   

Guarantor

   

Non-Guarantors

   

Eliminations

   

Total

 
                                         

NET SALES

  $ 66,455       1,450       30,123       (11,836 )     86,192  

COST OF SALES (exclusive of amortization shown separately below)

    21,797       1,046       18,990       (11,836 )     29,997  

GROSS MARGIN

    44,658       404       11,133       -       56,195  
                                         

OPERATING EXPENSES:

                                       

Research and development

    3,539       1,315       -       -       4,854  

Selling and marketing

    5,575       458       5,023       -       11,056  

Distribution

    2,843       57       1,688       -       4,588  

General and administrative

    7,583       444       2,419       -       10,446  

Amortization of intangibles

    11,770       54       583       -       12,407  

Total operating expenses

    31,310       2,328       9,713       -       43,351  
                                         

INCOME (LOSS) FROM OPERATIONS

    13,348       (1,924 )     1,420       -       12,844  
                                         

NON-OPERATING INCOME (EXPENSE):

                                       

Interest income

    -       -       35       (23 )     12  

Interest expense

    (21,970 )     -       (5 )     23       (21,952 )

Loss on extinguishment of debt

    (2,425 )     -       -       -       (2,425 )

Other, net

    (139 )     -       (4 )     -       (143 )

Total non-operating net expense

    (24,534 )     -       26       -       (24,508 )
                                         

(LOSS) INCOME BEFORE INCOME TAXES

    (11,186 )     (1,924 )     1,446       -       (11,664 )

(BENEFIT) PROVISION FOR INCOME TAXES

    (5,570 )     (695 )     514       -       (5,751 )

NET (LOSS) INCOME BEFORE EARNINGS OF CONSOLIDATED SUBSIDIARIES

    (5,616 )     (1,229 )     932       -       (5,913 )

Net Income (Loss) of consolidated subsidiaries

    (297 )     -       -       297       -  

NET (LOSS) INCOME

  $ (5,913 )     (1,229 )     932       297       (5,913 )
   

Immucor, Inc.

   

Guarantors

   

Non-Guarantors

   

Eliminations

   

Total

 
                                         

NET SALES

  $ 186,977       40,006       108,941       (48,698 )     287,226  

COST OF SALES (exclusive of amortization shown separately below)

    62,061       22,696       67,033       (48,698 )     103,092  

GROSS MARGIN

    124,916       17,310       41,908       -       184,134  
                                         

OPERATING EXPENSES:

                                       

Research and development

    10,314       11,654       210       -       22,178  

Selling and marketing

    18,387       6,847       18,523       -       43,757  

Distribution

    8,323       1,099       5,202       -       14,624  

General and administrative

    17,767       5,547       6,220       -       29,534  

Amortization of intangibles

    35,912       1,992       1,743       -       39,647  

Impairment loss

    30       150       -       -       180  

Acquisition-related items

    (4,638 )     -       -       -       (4,638 )

Total operating expenses

    86,095       27,289       31,898       -       145,282  
                                         

INCOME (LOSS) FROM OPERATIONS

    38,821       (9,979 )     10,010       -       38,852  
                                         

NON-OPERATING INCOME (EXPENSE):

                                       

Interest income

    1       8       55       (36 )     28  

Interest expense

    (66,182 )     -       (26 )     36       (66,172 )

Other, net

    (621 )     97       223       -       (301 )

Total non-operating (expense) income

    (66,802 )     105       252       -       (66,445 )
                                         

(LOSS) INCOME BEFORE INCOME TAXES

    (27,981 )     (9,874 )     10,262       -       (27,593 )

(BENEFIT) PROVISION FOR INCOME TAXES

    (11,523 )     (3,406 )     3,238       -       (11,691 )

NET (LOSS) INCOME BEFORE EARNINGS OF CONSOLIDATED SUBSIDIARIES

    (16,458 )     (6,468 )     7,024       -       (15,902 )

Net (Loss) Income of consolidated subsidiaries

    556       -       -       (556 )     -  

NET (LOSS) INCOME

  $ (15,902 )     (6,468 )     7,024       (556 )     (15,902 )
   

Immucor, Inc.

   

Guarantor

   

Non-Guarantors

   

Eliminations

   

Total

 
                                         

NET SALES

  $ 192,414       4,353       90,112       (33,477 )     253,402  

COST OF SALES (exclusive of amortization shown separately below)

    61,860       2,997       52,884       (33,477 )     84,264  

GROSS MARGIN

    130,554       1,356       37,228       -       169,138  
                                         

OPERATING EXPENSES:

                                       

Research and development

    9,822       4,419       35       -       14,276  

Selling and marketing

    19,277       1,396       15,545       -       36,218  

Distribution

    8,653       144       5,020       -       13,817  

General and administrative

    23,213       1,319       6,843       -       31,375  

Amortization of intangibles

    35,312       163       1,717       -       37,192  

Loss on disposition of fixed assets

    1,175       -       -       -       1,175  

Total operating expenses

    97,452       7,441       29,160       -       134,053  
                                         

INCOME (LOSS) FROM OPERATIONS

    33,102       (6,085 )     8,068       -       35,085  
                                         

NON-OPERATING INCOME (EXPENSE):

                                       

Interest income

                    74       (52 )     22  

Interest expense

    (68,726 )     -       (17 )     52       (68,691 )

Loss on extinguishment of debt

    (9,111 )     -       -       -       (9,111 )

Other, net

    (319 )     -       54       -       (265 )

Total non-operating (expense) income

    (78,156 )     -       111       -       (78,045 )
                                         

(LOSS) INCOME BEFORE INCOME TAXES

    (45,054 )     (6,085 )     8,179       -       (42,960 )

(BENEFIT) PROVISION FOR INCOME TAXES

    (16,549 )     (2,260 )     2,796       -       (16,013 )

NET (LOSS) INCOME BEFORE EARNINGS OF CONSOLIDATED SUBSIDIARIES

    (28,505 )     (3,825 )     5,383       -       (26,947 )

Net Income (Loss) of consolidated subsidiaries

    1,558       -       -       (1,558 )     -  

NET (LOSS) INCOME

  $ (26,947 )     (3,825 )     5,383       (1,558 )     (26,947 )
Condensed Cash Flow Statement [Table Text Block]
   

Immucor, Inc.

   

Guarantors

   

Non-Guarantors

   

Eliminations

   

Total

 
                                         

Net cash provided by (used in) operating activities

  $ 63       (2,351 )     13,732       (903 )     10,541  

Net cash provided by (used in) investing activities

    3,096       (1,954 )     (10,545 )     29       (9,374 )

Net cash ( used in) provided by financing activities

    (4,975 )     (34 )     (784 )     785       (5,008 )

Effect of exchange rate changes on cash and cash equivalents

    (501 )     -       893       89       481  

Change in cash and cash equivalents

    (2,317 )     (4,339 )     3,296       -       (3,360 )

Cash and cash equivalents at beginning of period

    6,971       4,107       18,310       -       29,388  

Cash and cash equivalents at end of period

  $ 4,654       (232 )     21,606       -       26,028  
   

Immucor, Inc.

   

Guarantor

   

Non-Guarantors

   

Eliminations

   

Total

 
                                         

Net cash (used in) provided by operating activities

  $ (16,071 )     2,464       8,691       88       (4,828 )

Net cash used in investing activities

    (3,798 )     (2,502 )     (615 )     -       (6,915 )

Net cash provided by financing activities

    12,543       -       -       -       12,543  

Effect of exchange rate changes on cash and cash equivalents

    -       -       231       (88 )     142  

Change in cash and cash equivalents

    (7,326 )     (38 )     8,306       -       942  

Cash and cash equivalents at beginning of period

    8,093       (144 )     10,629       -       18,578  

Cash and cash equivalents at end of period

  $ 767       (182 )     18,935       -       19,520